Theranostics,
Journal Year:
2023,
Volume and Issue:
13(5), P. 1607 - 1631
Published: Jan. 1, 2023
Nasopharyngeal
carcinoma
(NPC)
is
a
particular
entity
of
head
neck
cancer
that
generally
regarded
as
genetic
disease
with
diverse
intertumor
and
intratumor
heterogeneity.
This
perspective
review
mainly
outlines
the
up-to-date
knowledge
ecology
NPC
progression,
presents
number
conceptual
stepping-stones.
At
beginning,
I
explicitly
advocate
nature
(cancer)
not
but
an
ecological
disease:
multidimensional
spatiotemporal
"unity
evolution"
pathological
ecosystem.
The
hallmarks
proposed
to
act
factors
population
fitness.
Subsequently,
cells
are
described
invasive
species
its
metastasis
multidirectional
dispersal.
foundational
principles
include
intraspecific
relationship
(e.g.
communication)
interspecific
competition,
predation,
parasitism
mutualism)
interpreted
understand
progression.
"Mulberry-fish-ponds"
model
can
well
illustrate
dynamic
reciprocity
Tumor-host
interface
transition
zone
cancer,
tumor
buddings
should
be
recognized
islands
separated
from
mainland.
It
noted
tumor-host
has
significantly
molecular
functional
edge
effect
because
curvature
irregularity.
Selection
driving
therapy
including
hyperthermia
for
patients,
future
perspectives
in
such
field
"ecological
pathology",
"multidimensional
tumoriecology"
also
discussed.
advance
"nothing
evolution
or
makes
sense
except
light
other".
tree
constructed
comprehensively
point
out
research
direction.
Taken
together,
establishment
theory
might
provide
novel
framework
paradigm
our
understanding
complex
causal
process
potential
preventive
therapeutic
applications
patients.
Pharmacological Reviews,
Journal Year:
2022,
Volume and Issue:
74(3), P. 714 - 770
Published: June 23, 2022
The
first
matrix
metalloproteinase
(MMP)
was
discovered
in
1962
from
the
tail
of
a
tadpole
by
its
ability
to
degrade
collagen.
As
their
name
suggests,
metalloproteinases
are
proteases
capable
remodeling
extracellular
matrix.
More
recently,
MMPs
have
been
demonstrated
play
numerous
additional
biologic
roles
cell
signaling,
immune
regulation,
and
transcriptional
control,
all
which
unrelated
degradation
In
this
review,
we
will
present
milestones
major
discoveries
MMP
research,
including
various
clinical
trials
for
use
inhibitors.
We
discuss
reasons
behind
failures
most
inhibitors
treatment
cancer
inflammatory
diseases.
There
still
misconceptions
about
pathophysiological
best
strategies
inhibit
detrimental
functions.
This
review
aims
preclinical
models
human
pathologies.
new
biochemical
tools
track
proteolytic
activity
vivo
ex
vivo,
addition
future
pharmacological
alternatives
functions
Significance
Statement
Matrix
(MMPs)
implicated
inflammatory,
autoimmune,
cancers,
pathogen-mediated
Initially
overlooked,
contributions
can
be
both
beneficial
disease
progression
resolution.
Thousands
substrates
suggested,
few
hundred
validated.
After
more
than
60
years
there
remain
intriguing
enigmas
solve
regarding
biological
Science,
Journal Year:
2018,
Volume and Issue:
361(6406), P. 1033 - 1037
Published: Sept. 6, 2018
Metastases
are
responsible
for
the
majority
of
cancer-related
deaths.
Although
genomic
heterogeneity
within
primary
tumors
is
associated
with
relapse,
among
treatment-naïve
metastases
has
not
been
comprehensively
assessed.
We
analyzed
sequencing
data
76
untreated
from
20
patients
and
inferred
cancer
phylogenies
breast,
colorectal,
endometrial,
gastric,
lung,
melanoma,
pancreatic,
prostate
cancers.
found
that
individual
patients,
a
large
driver
gene
mutations
common
to
all
metastases.
Further
analysis
revealed
were
shared
by
unlikely
have
functional
consequences.
A
mathematical
model
tumor
evolution
metastasis
formation
provides
an
explanation
observed
homogeneity.
Thus,
single
biopsies
capture
most
functionally
important
in
therefore
provide
essential
information
therapeutic
decision-making.
Molecular Cancer Research,
Journal Year:
2023,
Volume and Issue:
21(11), P. 1142 - 1147
Published: July 6, 2023
Abstract
Most
definitions
of
cancer
broadly
conform
to
the
current
NCI
definition:
“Cancer
is
a
disease
in
which
some
body's
cells
grow
uncontrollably
and
spread
other
parts
body.”
These
tend
describe
what
“looks
like”
or
“does”
but
do
not
“is”
“has
become.”
While
reflecting
past
insights,
have
kept
pace
with
understanding
that
cell
itself
transformed
evolving.
We
propose
revised
definition
cancer:
Cancer
uncontrolled
proliferation
by
subject
evolution
natural
selection.
believe
this
captures
essence
majority
previous
definitions.
To
simplest
as
cells,
our
adds
adjective
“transformed”
capture
many
tumorigenic
processes
adopt
metastasize.
concept
proposed
then
“subject
selection.”
The
selection
modernizes
include
genetic
epigenetic
changes
accumulate
within
population
lead
lethal
phenotype.
Frontiers in Medicine,
Journal Year:
2018,
Volume and Issue:
5
Published: April 6, 2018
Today
clinical
evaluation
of
tumor
heterogeneity
today
is
an
emergent
issue
to
improve
oncology.
In
particular,
intra-tumor
(ITH)
closely
related
cancer
progression,
resistance
therapy,
and
recurrences.
It
interconnected
with
complex
molecular
mechanisms
including
spatial
temporal
phenomena,
which
are
often
peculiar
for
every
single
patient.
This
review
tries
describe
all
the
types
ITH
morpho-histological
ITH,
at
level
clonal
derived
from
genomic
instability
non-clonal
micro-environment
interaction.
important
consider
different
as
a
whole
any
patient
investigate
on
prognosis
treatment
opportunities.
From
practical
point
view
analytical
methods
that
widely
accessible
today,
or
will
be
in
near
future,
evaluated
pattern
reproducible
way
application.
Genome biology,
Journal Year:
2018,
Volume and Issue:
19(1)
Published: Dec. 1, 2018
Cellular
heterogeneity
within
and
across
tumors
has
been
a
major
obstacle
in
understanding
treating
cancer,
the
complex
is
masked
if
bulk
tumor
tissues
are
used
for
analysis.
The
advent
of
rapidly
developing
single-cell
sequencing
technologies,
which
include
methods
related
to
genome,
epigenome,
transcriptome,
multi-omics
sequencing,
have
applied
cancer
research
led
exciting
new
findings
fields
evolution,
metastasis,
resistance
therapy,
microenvironment.
In
this
review,
we
discuss
recent
advances
limitations
these
technologies
their
potential
applications
studies.
Cancer Research,
Journal Year:
2020,
Volume and Issue:
80(7), P. 1578 - 1589
Published: Jan. 16, 2020
A
new
ecologically
inspired
paradigm
in
cancer
treatment
known
as
"adaptive
therapy"
capitalizes
on
competitive
interactions
between
drug-sensitive
and
drug-resistant
subclones.
The
goal
of
adaptive
therapy
is
to
maintain
a
controllable
stable
tumor
burden
by
allowing
significant
population
treatment-sensitive
cells
survive.
These,
turn,
suppress
proliferation
the
less-fit
resistant
populations.
However,
there
remain
several
open
challenges
designing
therapies,
particularly
extending
these
therapeutic
concepts
multiple
treatments.
We
present
case
study
(metastatic
castrate-resistant
prostate
cancer)
point
departure
illustrate
three
novel
aid
design
multidrug
therapies.
First,
frequency-dependent
"cycles"
evolution
can
trap
periodic,
loop.
Second,
availability
selection
treatments
may
limit
evolutionary
"absorbing
region"
reachable
tumor.
Third,
velocity
significantly
influences
optimal
timing
drug
sequences.
These
conceptual
advances
provide
path
forward
for
therapy.
SIGNIFICANCE:
Driving
into
repeatable
cycles
provides
Journal for ImmunoTherapy of Cancer,
Journal Year:
2018,
Volume and Issue:
6(1)
Published: Dec. 1, 2018
A
high
density
of
tumor-infiltrating
CD8+
T
cells
and
CD20+
B
correlates
with
prolonged
survival
in
patients
a
wide
variety
human
cancers,
including
high-grade
serous
ovarian
carcinoma
(HGSC).
However,
the
potential
impact
mature
dendritic
(DCs)
shaping
immune
contexture
HGSC,
their
role
establishment
cell-dependent
antitumor
immunity,
prognostic
value
for
HGSC
remain
unclear.
We
harnessed
immunohistochemical
tests
biomolecular
analyses
to
demonstrate
that
DC-LAMP+
DCs
is
robustly
associated
an
characterized
by
TH1
polarization
cytotoxic
activity.
showed
both
play
critical
generation
clinically-favorable
response
microenvironment.
In
line
this
notion,
robust
tumor
infiltration
was
most
favorable
overall
two
independent
cohorts
chemotherapy-naïve
patients.
Our
findings
suggest
presence
mature,
microenvironment
may
represent
novel,
powerful
biomarker
reflects
activation
clinically-relevant
anticancer
immunity.